Matt Bridgland-Taylor

Statistics

Publications

Citations

163

H-Index

Active since

2006

Affiliations

AstraZeneca (United Kingdom)(Current)

Matt Bridgland-Taylor is an author at AstraZeneca (United Kingdom) specializing in cardiovascular pharmacology, cardiovascular pharmacodynamics, and biomedical engineering.

Publications per year

2006–2014

Publications

Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks™ HT

Matt Bridgland-Taylor, Alee Hargreaves, Alison Easter et al. · Journal of Pharmacological and Toxicological Methods · 2006 · 150 citations

Engineering, Bioengineering, Biomedical Engineering +9

Predicting changes in cardiac myocyte contractility during early drug discovery with in vitro assays

Michael J. Morton, Duncan Armstrong, Najah Abi Gerges et al. · Toxicology and Applied Pharmacology · 2014 · 13 citations

Medicine, Cardiology, Pharmacology +15

1–2 of 2